Protara Therapeutics Inc (TARA) — Cash Flow Reinvestment Rate
Latest as of September 2023:
50.12x
Protara Therapeutics Inc (TARA) has a Cash Flow Reinvestment Rate of 50.12x as of September 2023, reinvesting $6.42 Million (capex $37.00K plus investments $6.38 Million) from operating cash flow of $128.00K. Check TARA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
50.12x
(Capex + Investments) / Operating CF
Total Reinvested
$6.42 Million
Capex + Investments
Operating Cash Flow
$128.00K
USD
Capital Expenditures
$37.00K
USD
Annual Cash Flow Reinvestment Rate for Protara Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Protara Therapeutics Inc. For live market cap and broader valuation context, see Protara Therapeutics Inc (TARA) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow